IndiaTickerICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source Company dossier
Lincoln Pharmaceuticals
NSE:LINCOLN · ISIN INE405C01035
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Lincoln Pharmaceuticals
Ratings & risks
Credit signals
Agency evidenceRating-action history
ICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source ICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings reaffirmed and rated amount enhancedICRA Limited · discovered
Agency source ICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source ICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings upgraded; outlook revised to âStableâ from âPositiveâICRA Limited · discovered
Agency source ICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings reaffirmed, outlook revised to PositiveICRA Limited · discovered
Agency source ICRA Limited · Lincoln Pharmaceuticals Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source ICRA Limited · Lincoln Pharmaceuticals Limited: Ratings Reaffirmed, rated amount enhancedICRA Limited · discovered
Agency source ICRA Limited · ICRA reaffirms the ratings of [ICRA]A- and [ICRA]A2+ to the bank facilities of Lincoln Pharmaceuticals Limited; Outlook revised from 'Negative' to 'Stable'ICRA Limited · discovered
Agency source Risk research framework
Analyst reviewQuestions to test against evidence
Operating deterioration
HighTrack sector-specific operating metrics and reconcile them across reporting periods.
Funding and liquidity
HighReview debt maturity, repricing, liquidity and rating commentary where relevant.
Execution versus guidance
MediumCompare management statements with subsequent reported delivery.
Governance and key-person change
MediumConnect management transitions, related parties and auditor observations.